In vivo effects of 3-iodocytisine: Pharmacological and genetic analysis of hypothermia and evaluation of chronic treatment on nicotinic binding sites

Neuropharmacology

Volumn 57, Issue 3, 2009, Pages 332-342

  Zambrano, C A ^a,b   Marks, M J ^b   Cassels, B K ^a   Maccioni, R B ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Bungarotoxin; 3 iodocytisine; Epibatidine; Hypothermia; Nicotinic acetylcholine receptors; Null mutant mice

Indexed keywords

3 IODOCYTISINE; ALPHA BUNGAROTOXIN; EPIBATIDINE; HEXAMETHONIUM; MECAMYLAMINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; BRAIN CORTEX; BRAIN REGION; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; GENETIC ANALYSIS; HIPPOCAMPUS; HYPOTHERMIA; IN VIVO STUDY; LIGAND BINDING; MEMBRANE BINDING; MOUSE; MOUSE MUTANT; NONHUMAN; PRIORITY JOURNAL; THERMOREGULATION; WILD TYPE;

ALKALOIDS; ANIMALS; AZOCINES; BINDING SITES; BRAIN; CELL MEMBRANE; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; HIPPOCAMPUS; HYPOTHERMIA; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, KNOCKOUT; QUINOLIZINES; RANDOM ALLOCATION; RECEPTORS, NICOTINIC;

EID: 67650988866     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2009.05.004     Document Type: Article

References (43)

1. Abin-Carriquiry J.A., Voutilainen M.H., Barik J., Cassels B.K., Iturriaga-Vasquez P., Bermudez I., Durand C., Dajas F., and Wonnacott S. C3-halogenation of cytisine generates potent and efficacious nicotinic receptor agonists. European Journal of Pharmacology 536 (2006) 1-11
2. Barr J.E., Holmes D.B., Ryan L.J., and Sharpless S.K. Techniques for the chronic cannulation of the jugular vein in mice. Pharmacology, Biochemistry and Behavior 11 (1979) 115-118
3. Bourin M., Ripoll N., and Dailly E. Nicotinic receptors and Alzheimer's disease. Current Medical Research and Opinion 19 (2003) 169-177
4. Conroy W.G., and Berg D.K. Neurons can maintain multiple classes of nicotinic acetylcholine receptors distinguished by different subunit compositions. Journal of Biological Chemistry 270 (1995) 4424-4431
5. Dani J.A., and Bertrand D. Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annual Review of Pharmacology and Toxicology 47 (2007) 699-729
6. Dani J.A., and DeBiasi M. Cellular mechanism of nicotine addiction. Pharmacology Biochemistry and Behavior 70 (2001) 439-446
7. 125I]epibatidine in adrenal gland, superior cervical ganglia, pineal or retina. Journal of Neurochemistry 85 (2003) 1237-1246
8. Flores C.M., Rogers S.W., Pabreza L.A., Wolfe B.B., and Kellar K.J. A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment. Molecular Pharmacology 41 (1992) 31-37
9. Gordon C.J. The therapeutic potential of regulated hypothermia. Emergency Medicine Journal 18 (2001) 81-89
10. Harris J.G., Kongs S., Allensworth D., Martin L., Tregellas J., Sullivan B., Zerbe G., and Freedman R. Effects of nicotine on cognitive deficits in schizophrenia. Neuropsychopharmacology 29 (2004) 1378-1385
11. Hogg R.C., and Bertrand D. Neuronal nicotinic receptors and epilepsy, from genes to possible therapeutic compounds. Bioorganic and Medicinal Chemistry Letters 14 (2004) 1859-1861
12. Imming P., Klaperski P., Stubbs M.T., Seitz G., and Gündisch D. Syntheses and evaluation of halogenated cytisine derivatives and of bioisosteric thiocytisine as potent and selective nAChR ligands. European Journal of Medicinal Chemistry 36 (2001) 375-388
13. Lam S., and Patel P.N. Varenicline: a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist approved for smoking cessation. Cardiology in Review 15 (2007) 154-161
14. Leonard S., Adler L.E., Benhammou K., Berger R., Breese C.R., Drebing C., Gault J., Lee M.J., Logel J., Olincy A., Ross R.G., Stevens K., Sullivan B., Vianzon R., Virnich D.E., Waldo M., Walton K., and Freedman R. Smoking and mental illness. Pharmacology Biochemistry and Behavior 70 (2001) 561-570
15. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193 (1951) 265-275
16. Luetje C.W., and Patrick J. Both alpha- and beta-subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors. The Journal of Neuroscience 11 (1991) 837-845
17. Lukas R.J., Changeux J.P., Le Novère N., Albuquerque E.X., Balfour D.J., Berg D.K., Bertrand D., Chiappinelli V.A., Clarke P.B., Collins A.C., Dani J.A., Grady S.R., Kellar K.J., Lindstrom J.M., Marks M.J., Quik M., Taylor P.W., and Wonnacott S. International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. Pharmacological Reviews 51 (1999) 397-401
18. Marks M.J., Burch J.B., and Collins A.C. Genetics of nicotine response in four inbred strains of mice. The Journal of Pharmacology and Experimental Therapeutics 226 (1983) 291-302
19. Marks M.J., Burch J.B., and Collins A.C. Effects of chronic nicotine infusion on tolerance development and nicotinic receptors. The Journal of Pharmacology and Experimental Therapeutics 226 (1983) 817-825
20. 125I]-epibatidine binding sites in C57BL/6J mouse brain are differentially affected by chronic nicotine treatment. Neuropharmacology 46 (2004) 1141-1157
21. McCallum S.E., Collins A.C., Paylor R., and Marks M.J. Deletion of the beta 2 nicotinic acetylcholine receptor subunit alters development of tolerance to nicotine and eliminates receptor upregulation. Psychopharmacology (Berlin) 184 (2006) 314-327
22. Nguyen H.N., Rasmussen B.A., and Perry D.C. Subtype-selective up-regulation by chronic nicotine of high-affinity nicotinic receptors in rat brain demonstrated by receptor autoradiography. The Journal of Pharmacology and Experimental Therapeutics 307 (2003) 1090-1097
23. Olsen T.S., Weber U.J., and Kammersgaard L.P. Therapeutic hypothermia for acute stroke. Lancet Neurology 2 (2003) 410-416
24. Orr-Urtreger A., Goldner F.M., Saeki M., Lorenzo I., Goldberg L., De Biasi M., Dani J.A., Patrick J.W., and Beaudet A.L. Mice deficient in the alpha7 neuronal nicotinic acetylcholine receptor lack alpha-bungarotoxin binding sites and hippocampal fast nicotinic currents. The Journal of Neuroscience 17 (1997) 9165-9171
25. Pauly J.R., Stitzel J.A., Marks M.J., and Collins A.C. An autoradiographic analysis of cholinergic receptors in mouse brain. Brain Research Bulletin 22 (1989) 453-459
26. Pauly J.R., Marks M.J., Gross S.D., and Collins A.C. An autoradiographic analysis of cholinergic receptors in mouse brain after chronic nicotine treatment. The Journal of Pharmacology and Experimental Therapeutics 258 (1991) 1127-1136
27. 3H]cytisine binding to nicotinic cholinergic receptors in brain. Molecular Pharmacology 39 (1991) 9-12
28. Picciotto M.R. Nicotine as a modulator of behavior: beyond the inverted U. Trends in Pharmacological Sciences 24 (2003) 493-499
29. Picciotto M.R., Zoli M., Léna C., Bessis A., Lallemand Y., Le Novère N., Vincent P., Pich E.M., Brulet P., and Changeux J.P. Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain. Nature 374 (1995) 65-67
30. Quick M.W., and Lester R.A.J. Desensitization of neuronal nicotinic receptors. Journal of Neurobiology 53 (2002) 457-478
31. Quik M. Smoking, nicotine and Parkinson's disease. Trends in Neurosciences 27 (2004) 561-568
32. 125I]alpha-bungarotoxin binding in rat brain after chronic nicotine exposure. Neuroscience Letters 404 (2006) 9-14
33. Sack R., Gochberg-Sarver A., Rozovsky U., Kedmi M., Rosner S., and Orr-Urtreger A. Lower core body temperature and attenuated nicotine-induced hypothermic response in mice lacking the beta4 neuronal nicotinic acetylcholine receptor subunit. Brain Research Bulletin 66 (2005) 30-36
34. Salminen O., Murphy K.L., McIntosh J.M., Drago J., Marks M.J., Collins A.C., and Grady S.R. Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice. Molecular Pharmacology 65 (2004) 1526-1535
35. Salin-Pascual R.J., and Basanez-Villa E. Changes in compulsion and anxiety symptoms with nicotine transdermal patches in non-smoking obsessive-compulsive disorder patients. Revista de Investigacion Clinica 55 (2003) 650-654
36. Slater Y.E., Houlihan L.M., Maskell P.D., Exley R., Bermudez I., Lukas R.J., Valdivia A.C., and Cassels B.K. Halogenated cytisine derivatives as agonists at human neuronal nicotinic acetylcholine receptor subtypes. Neuropharmacology 44 (2003) 503-515
37. Sloan J.W., Martin W.R., Bostwick M., Hook R., and Wala E. The comparative binding characteristics of nicotinic ligands and their pharmacology. Pharmacology Biochemistry and Behavior 30 (1988) 255-267
38. Sparks J.A., and Pauly J.R. Effects of continuous oral nicotine administration on brain nicotinic receptors and responsiveness to nicotine in C57BL/6J mice. Psychopharmacology (Berlin) 141 (1999) 145-153
39. Tritto T., McCallum S.E., Waddle S.A., Hutton S.R., Paylor R., Collins A.C., and Marks M.J. Null mutant analysis of responses to nicotine: deletion of β2 nicotinic acetylcholine receptor subunit but not α7 subunit reduces sensitivity to nicotine-induced locomotor depression and hypothermia. Nicotine and Tobacco Research 6 (2004) 145-157
40. Varas R., Valdés V., Iturriaga-Vásquez P., Cassels B.K., Iturriaga R., and Alcayaga J. Electrophysiological characterization of nicotinic acetylcholine receptors in cat petrosal ganglion neurons in culture: effects of cytisine and its bromo derivatives. Brain Research 1072 (2006) 72-78
41. 125I]-epibatidine. British Journal of Pharmacology 131 (2000) 729-739
42. 125I-alpha-conotoxin ArIB[V11L;V16A], a selective alpha7 nicotinic acetylcholine receptor antagonist. The Journal of Pharmacology and Experimental Therapeutics 325 (2008) 910-919
43. Xu W., Orr-Urtreger A., Nigro F., Gelber S., Sutcliffe C.B., Armstrong D., Patrick J.W., Role L.W., Beaudet A.L., and De Biasi M. Multiorgan autonomic dysfunction in mice lacking the beta2 and the beta4 subunits of neuronal nicotinic acetylcholine receptors. The Journal of Neuroscience 19 (1999) 9298-9305